SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crypto memecoin CAW.X, also known as crow with knife, is trending due to its enthusiastic community and recent mentions of potential listings. Community members highlight its unique attributes, multichain functionality across SOL, BSC, CRO, and ETH, and deflationary burn mechanism. Some community members are comparing it to established memecoins and calling it the top memecoin.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending due to increased interest in nuclear energy and its potential to power AI data centers, despite the company having no current revenue. The community is debating the stock's high valuation relative to its stage of development, with some anticipating a pullback or secondary offering, while others remain bullish due to the sector's momentum and potential government support. Discussions also highlight comparisons to other energy companies and the potential for a short squeeze.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending following news of a large AI server contract, sparking excitement among investors. Community members are actively discussing potential short squeezes due to the stock's low float and high cost to borrow, while others debate the company's long-term potential within the growing IoT sector.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to community discussion surrounding the potential approval of their drug, Deramiocel, for Duchenne Muscular Dystrophy (DMD).  The community is focused on the FDA's feedback from a recent Type A meeting and the potential for accelerated approval, referencing competitor Stealth Bio's recent accelerated approval as a hopeful sign. Discussions also highlight the advocacy efforts of DMD patients and their families, who are actively lobbying for the drug's approval, emphasizing the urgent need for treatment options.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as traders discuss a potential short squeeze and draw comparisons to other AI defense stocks like Palantir. The community is focused on key resistance levels, anticipating a continued rally and eyeing a move towards higher price targets. Some traders speculate on upcoming news or contract announcements as potential catalysts for further growth.

Terner is an AI-powered platform on Solana that enables users to create, deploy, and crowdfund innovative projects through natural language interaction. The platform combines advanced AI capabilities with blockchain technology to democratize project creation, offering tools for building web applications, bots, and various digital solutions while providing automated deployment and investment opportunities for creators and investors alike.

Terner

Terner ($TERNER.X) is trending as the community discusses its potential within the Solana ecosystem, highlighting its AI-powered project creation capabilities. Investors are actively accumulating, citing strong buying pressure and anticipating significant gains. Community members are closely monitoring on-chain stats using Phantom.

B. Riley Financial, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

B. Riley Financial Inc

B. Riley Financial is trending as investors await the overdue 10-K filing, with many believing its release will trigger a short squeeze. The community is actively discussing potential catalysts, including interest rate decisions and positive business momentum, while expressing frustration over the delays and concerns about the company's compliance. Despite recent losses and auditor changes, some see a turnaround and significant upside potential once the filings are resolved.

CEA Industries, Inc. engages in in the development, design, and distribution of cultivation technologies for controlled environment agriculture, primarily for cannabis crops. It offers controlled climate systems, controls, and biosecurity cultivation products, and MEP engineering, odor control, and installation support services. The company was founded by Brandy Marie Keen and Stephen Keen on October 15, 2009 and is headquartered in Louisville, CO.

CEA Industries Inc

CEA Industries (BNC) is trending due to discussions around its significant BNB holdings and a recent share buyback announcement, with community members debating the implications of a potentially high short interest and a low float. Some are speculating about a possible short squeeze, while others focus on the company's valuation relative to its assets. The focus remains on the relationship between the stock price, the company's BNB treasury, and potential market manipulation.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid discussions around freedom of speech, censorship, and political polarization, particularly following news about Jimmy Kimmel and a resolution honoring Charlie Kirk. The community is fiercely debating the implications of these events, with opinions split along ideological lines. Broader discussions encompass media influence, government overreach, and the role of political figures in shaping public discourse.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as community members celebrate its joke-inspired origins and its listing on Jupiter. Many are loading up on the $SOL-based meme coin, while also playfully asking, "What's Updog?" The community is also highlighting the project's donations to animal shelters.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Inspire (INSP) Up 7.5% Since Last Earnings Report?

Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is the Options Market Predicting a Spike in Inspire Medical Systems Stock?

Investors need to pay close attention to INSP stock based on the movements in the options market lately.

Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea

NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.

Shares of Inspire Medical Systems, Inc. (INSP) slumped 42% on Tuesday after multiple analysts downgraded the stock on the heels of the company lowering its full-year earnings guidance.The company, which develops solutions for patients with obstructive sleep apnea, cut its full-year revenue guidance on Monday to the range of $900 million to $910 million, down from its previous guidance of $940 to $955 million.Truist downgraded Inspire Medical to ‘Hold’ from ‘Buy’ with a price target of $125, down from $190. The firm was braced for a guidance cut, but it was bigger than expected, and a lower earnings per share outlook reduces the stock valuation floor, the analyst told investors in a post-earnings note.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/INSP">INSP</a> jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:1250/126;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_05_at_12_28_15_PM_png_dbcc9ea28f.webp" alt="INSP's Sentiment Meter and Message Volume as of 12:20 p.m. ET on Aug. 5, 2025 | Source: Stocktwits" width="1250" height="126"><figcaption>INSP's Sentiment Meter and Message Volume as of 12:20 p.m. ET on Aug. 5, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that the shares are way oversold and will bounce in a few days.<stembedurl>https://stocktwits.com/Sharksbuffs/message/623795533</stembedurl>Inspire now anticipates diluted net income per share guidance for the full year 2025 to be in the range of $0.40 to $0.50, down from its prior guidance of $2.20 to $2.30 per share.Other analysts, too, have downgraded the stock or have cut their price target.<ul style="list-style-type:square;"><li>KeyBanc downgraded the shares to ‘Sector Weight’ from ‘Overweight’ without a price target.&nbsp;</li><li>JPMorgan analyst Robbie Marcus downgraded Inspire Medical to ‘Neutral’ from ‘Overweight’ with a price target of $110, down from $195.&nbsp;</li><li>Piper Sandler kept its ‘Overweight’ rating on the stock while lowering the price target on the shares to $150 from $233. While the firm believed there could be a downward revision, it was disappointed by the magnitude of the cut to both the top and bottom-line guides, it said.</li></ul> INSP stock is down by 59% this year and by 48% over the past 12 months. &nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/ardelyx-stock-soars-on-price-target-hikes-after-upbeat-q2-report/chrLvsyRd28">Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions Coming</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Inspire Medical Systems Stock Slumps On Downgrades, Price Target Cuts: Retail Believes Stock Is Way Oversold

Truist said it was braced for a guidance cut, but it was bigger than expected, and a lower earnings per share outlook reduces the stock valuation floor.

Equity

INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts

Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.

Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics

The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Inspire Medical Systems (INSP) Q2 Earnings and Revenues Surpass Estimates

Inspire (INSP) delivered earnings and revenue surprises of +104.55% and +0.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Misses Revenue Estimates

Butterfly Network (BFLY) delivered earnings and revenue surprises of +14.29% and -2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Doximity (DOCS) Reports Next Week: Wall Street Expects Earnings Growth

Doximity (DOCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?

Hims & Hers benefits from strong product demand and subscriber growth ahead of second-quarter 2025 earnings, fueled by weight loss and specialty care uptake.

Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Inspire Medical Systems Inc

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Current Price	$79.88
Prev Close	$83.40
Open	$83.60
Dividend Yield	0.00%
50-Day Moving Average	$101.55
Beta	1.11
Avg. Volume	1.68M
PE Ratio	48.31

52-Week High	$218.52
52-Week Low	$73.92
Market Capitalization	$2.47B
EPS (Annual)	$1.75
Price to Book	3.64
Revenue Per Employee	$644,304.98
Enterprise Value/EBITDA	N/A

INSP
Inspire Medical Systems Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INSP News

INSP Inspire Medical Systems Inc